SweetValueLab
Write for us

Baxter International Inc. — Financial Statements & Ratios

BAX
NYSEHealthcareMedical - Instruments & SuppliesCIK 0000010456baxter.comAbout BAX
Last close · Oct 16, 202625.28−0.48 (−1.86%)
Market cap$13.1B

Key indicators

Revenue11.5BTTM+5.4% on a year earlier+0.1% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
11.1B 11.4B+2.1%11.7B+2.7%12.8B+9.5%15.1B+18.2%14.8B−2.0%10.6B−28.2%11.2B+5.7%11.5B+5.4%11.6B 11.9B 12.1B
— 2.1% 2.7% 9.5% 18.2% -2.0% -28.2% 5.7% 5.4% 3.3% 2.2% 2.3%
$2.97 $1.93−35.0%$2.13+10.4%$2.53+18.8%-$4.83−290.9%$5.25+208.7%-$1.27−124.2%-$1.87−47.2%-$2.09−574.2%$2.05 $2.04 $2.17
Profitability
43.0% 41.9%−1.1 pt39.3%−2.6 pt39.9%+0.6 pt35.7%−4.2 pt33.6%−2.1 pt37.5%+3.9 pt30.1%−7.4 pt30.1%−5.2 pt· · ·
14.4% 15.6%+1.2 pt13.8%−1.8 pt13.4%−0.5 pt-12.9%−26.2 pt2.6%+15.5 pt0.1%−2.5 pt-2.7%−2.9 pt-2.4%−2.1 pt· · ·
14.6% 8.8%−5.8 pt9.4%+0.6 pt10.0%+0.6 pt-16.1%−26.1 pt17.9%+34.0 pt-6.1%−24.0 pt-8.5%−2.4 pt-9.3%−7.8 pt· · ·
— 12.7% 12.7%−0.0 pt14.1%+1.5 pt-41.7%−55.9 pt31.6%+73.3 pt-9.3%−40.9 pt-15.6%−6.3 pt— · · ·
Cash
1.4B 1.4B−0.5%1.2B−17.7%1.5B+27.6%532.0M−64.0%1.0B+94.4%573.0M−44.6%332.0M−42.1%815.0M · · ·
12.7% 12.4%−0.3 pt9.9%−2.5 pt11.6%+1.6 pt3.5%−8.0 pt7.0%+3.5 pt5.4%−1.6 pt3.0%−2.4 pt7.1% · · ·
376.0M 423.0M+12.5%473.0M+11.8%530.0M+12.1%573.0M+8.1%586.0M+2.3%590.0M+0.7%348.0M−41.0%— · · ·
Balance sheet
— 0.68x 0.71x+0.03x1.95x+1.23x2.85x+0.91x1.64x−1.21x1.88x+0.24x1.55x−0.34x0.14x+0.13x· · ·
546.00M 519.00M−4.9%517.00M−0.4%508.00M−1.7%504.00M−0.8%506.00M+0.4%510.00M+0.8%513.00M+0.6%518.00M+0.8%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.